View Clinical Trial (Medical Research Study)
Brief Cognitive Behavioral Therapy (CBT) for Pediatric Anxiety and Depression in Primary Care - NCT01147614-15213(Clinical Trial 680183)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Pittsburgh |
|
State:
|
|
PA |
| Zip Code: |
|
15213 |
| Conditions: |
|
Anxiety - Depression |
| Purpose: |
|
The purpose of this study is to determine whether a brief (12 week) psychological treatment
program, based in primary care, can help youths struggling with anxiety and/or depression.
This brief cognitive behavioral therapy program will be compared to enhanced referral to
specialty mental health care.
|
| Study summary: |
|
Mood and anxiety disorders in childhood and adolescence are disabling, distressing, and
prevalent and produce added costs to health systems. This two-site randomized controlled
trial will test the effects of a brief cognitive behavioral therapy (BCBT) protocol (8-12
sessions) in a large sample (N=210) of children and adolescents (age 8-16) presenting with
anxiety and/or depression in primary care. Clinical and cost-effectiveness of BCBT will be
compared to a plausible public health alternative - enhanced referral to specialty mental
health care (SMHC). This investigation is noteworthy in adopting a deployment-focused model
and testing this intervention early in its development within a real world context (primary
care) and against a plausible public health comparison condition (SMHC) relevant for future
treatment dissemination. |
| Criteria: |
|
Inclusion Criteria:
- meet full or probable diagnostic criteria for Separation Anxiety Disorder,
Generalized Anxiety Disorder, Social Phobia, Major Depression, Dysthymic Disorder, or
Minor Depression
- age 8.0 to 16.9
- live with legal, consenting guardian for at least 6 months
Exclusion Criteria:
- youths requiring alternate intervention (e.g., youths with bipolar disorder,
psychosis, active suicidal ideation with plan, PTSD, substance dependence, current
physical or sexual abuse, or mental retardation
- suffer from serious or unstable physical illness (e.g., uncontrolled diabetes)
- currently in active, alternate intervention for anxiety or depression (e.g.,
antidepressant use) |
|
|
|
| Study is available at: |
|
Western Psychiatric Institute and Clinics
Pittsburgh, PA 15213
United States
Primary Contact:
Donna L Moyles, M.S.
Email: moylesdl@upmc.edu
Phone: 412-246-5283
Secondary Contact:
Michelle S Rozenman, M.S.
Email: mrozenma@ucsd.edu
Phone: (619) 594-8898 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 23, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|